They would not be allowed to use IP in the non-US part, so they would have to split their R&D, too, either spending twice what they do for the same revenues or

They would not be allowed to use IP in the non-US part, so they would have to split their R&D, too, either spending twice what they do for the same revenues or slowing down innovation.